Integrin Inhibitor (Clearside Biomedical)

N/A

Report date: 2025/01/26 19:09:49
NME

Base Information

Drug NameIntegrin Inhibitor (Clearside Biomedical)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin antagonists
TargetsIntegrin
Therapy Area/IndicationsDiabetic macular oedema
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesClearside Biomedical Inc
China Registration ClassN/A

Develop Information

Active CompaniesClearside Biomedical Inc
Inactive CompaniesN/A
Active IndicationsDiabetic macular oedema
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A